These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 15585566

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
    O'Neill K, Chen S, Brinton RD.
    Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
    [Abstract] [Full Text] [Related]

  • 23. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.
    Miki Y, Suzuki T, Nagasaki S, Hata S, Akahira J, Sasano H.
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):281-9. PubMed ID: 19429434
    [Abstract] [Full Text] [Related]

  • 24. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ, Levy N, Zhao X, Griffin C, Tagliaferri M, Cohen I, Ricke WA, Speed TP, Firestone GL, Leitman DC.
    Mol Cell Endocrinol; 2009 Feb 27; 299(2):204-11. PubMed ID: 19059307
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1.
    Peri A, Serio M.
    J Mol Endocrinol; 2008 Nov 27; 41(5):251-61. PubMed ID: 18768664
    [Abstract] [Full Text] [Related]

  • 28. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
    Michael H, Härkönen PL, Kangas L, Väänänen HK, Hentunen TA.
    Br J Pharmacol; 2007 Jun 27; 151(3):384-95. PubMed ID: 17420779
    [Abstract] [Full Text] [Related]

  • 29. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.
    Cancer; 2006 Jun 15; 106(12):2610-6. PubMed ID: 16700038
    [Abstract] [Full Text] [Related]

  • 30. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC, Burger CW, Kühne LC, Hanifi-Moghaddam P, Blok LJ.
    J Soc Gynecol Investig; 2005 Oct 15; 12(7):e55-67. PubMed ID: 16202921
    [Abstract] [Full Text] [Related]

  • 31. Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
    Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti S, Nesi G, Valeri A, Greeve I, Serio M, Mannelli M, Peri A.
    J Clin Endocrinol Metab; 2004 Mar 15; 89(3):1332-9. PubMed ID: 15001630
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
    Ishihara Y, Itoh K, Ishida A, Yamazaki T.
    J Steroid Biochem Mol Biol; 2015 Jan 15; 145():85-93. PubMed ID: 25305410
    [Abstract] [Full Text] [Related]

  • 34. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
    Salvatori L, Caporuscio F, Coroniti G, Starace G, Frati L, Russo MA, Petrangeli E.
    J Cell Physiol; 2009 Jul 15; 220(1):35-44. PubMed ID: 19347870
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
    Suuronen T, Nuutinen T, Huuskonen J, Ojala J, Thornell A, Salminen A.
    Inflamm Res; 2005 May 15; 54(5):194-203. PubMed ID: 15953991
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
    Bläuer M, Heinonen PK, Rovio P, Ylikomi T.
    Eur J Pharmacol; 2008 Sep 11; 592(1-3):13-8. PubMed ID: 18638473
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
    Zhao L, O'Neill K, Brinton RD.
    J Pharmacol Exp Ther; 2006 Dec 11; 319(3):1124-32. PubMed ID: 16951259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.